WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

D DERMATOLOGICALS

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.


D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS

As a main rule, all topical corticosteroid preparations should be classified in this group. There are, however, some few exceptions:

Combinations of corticosteroids and antiinfectives for gynaecological use, see G01B.

Corticosteroids for local oral treatment, see A01AC.

Anti-acne preparations, see D10A.

Antihemorrhoidals with corticosteroids, see C05AA.

Corticosteroids for ophthalmological or otological use, see S - Sensory organs.


D07A CORTICOSTEROIDS, PLAIN

The group is subdivided according to clinical potency of the steroids as such. Additional agents meant to enhance the penetration and increase the potency of the product do not influence the classification, neither do the strength of the preparations or the vehicle.


D07AC Corticosteroids, potent (group III)

    ATC code  Name  DDD  U Adm.R Note
    D07AC12  halometasone    

List of abbreviations

Last updated: 2013-12-19